Effect of Bacillus subtilis DSM 32315 on the intestinal structural integrity and growth performance of broiler chickens under necrotic enteritis challenge.
- 2019-11
- Poultry Science 98(11)
- A. Sokale
- A. Menconi
- G. Mathis
- B. Lumpkins
- M. Sims
- R. Whelan
- K. Doranalli
- PubMed: 31250009
- DOI: 10.3382/ps/pez368
Abstract
The effect of dietary inclusion of Bacillus subtilis DSM 32315 on the intestinal health and growth performance of Cobb 500 male broilers subjected to a Clostridium perfringens-induced necrotic enteritis (NE) challenge was determined in 2 experiments. In experiment 1, chicks were randomly assigned to 4 treatments of 10 replicate/treatment. In experiment 2, chicks were randomly assigned to 4 treatments of 12 replicates/treatment. The experimental treatments were non-infected, non-supplemented control, infected, non-supplemented control (IC), infected + Bacillus subtilis DSM 32315 (B. subtilis DSM 32315), infected + bacitracin methylene disalicylate (BMD). In both experiments, NE was induced by oral inoculation of toxin producing C. perfringens on 3 consecutive days between 17 and 20 D of age, following exposure of birds to pre-disposing conditions. At day 28 (experiment 1), broilers fed diets with B. subtilis DSM 32315 exhibited a significantly higher body weight, lower mortality, and intestinal NE lesion score, compared to the IC treatment. At day 42 (experiment 2), B. subtilis DSM 32315 supplementation significantly improved BW, feed conversion ratio, production efficiency factor, NE lesion score, and mortality, compared to IC treatment. The effect of B. subtilis DSM 32315 on intestinal integrity of NE challenged chickens was evaluated with histomorphometry. A significantly shallower crypt depth and higher villus height to crypt depth ratio were observed in the mid-intestine of birds belonging to the B. subtilis DSM 32315 group, compared to the IC group. Furthermore, B. subtilis DSM 32315 supplementation significantly reduced the enteritis index associated with NE. In both experiments, the effect of B. subtilis DSM 32315 on the phenotypic measurements of NE and performance was comparable to the effect observed with BMD supplementation. In conclusion, supplementation of the direct fed microbial strain B. subtilis DSM 32315 can ameliorate the pathology and performance detriments associated with NE.
Keywords: Bacillus subtilis; Clostridium perfringens; broiler; necrotic enteritis; performance.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Bacillus subtilis AB22 | Improved Body Weight | Beneficial | Large |
Bacillus subtilis AB22 | Improved Feed Conversion Ratio | Beneficial | Large |
Bacillus subtilis AB22 | Improved Production Efficiency | Beneficial | Large |
Bacillus subtilis AB22 | Increased Villus Height to Crypt Depth Ratio | Beneficial | Moderate |
Bacillus subtilis AB22 | Reduced Colitis-Related Mortality | Beneficial | Large |
Bacillus subtilis AB22 | Reduced Crypt Depth | Beneficial | Moderate |
Bacillus subtilis AB22 | Reduced Enteritis Index | Beneficial | Large |
Bacillus subtilis AB22 | Reduced Intestinal NE Lesion Score | Beneficial | Large |
Bacillus subtilis SNZ-1972 | Improved Body Weight | Beneficial | Large |
Bacillus subtilis SNZ-1972 | Improved Feed Conversion Ratio | Beneficial | Large |
Bacillus subtilis SNZ-1972 | Increased Villus Height to Crypt Depth Ratio | Beneficial | Moderate |
Bacillus subtilis SNZ-1972 | Reduced Colitis-Related Mortality | Beneficial | Large |
Bacillus subtilis SNZ-1972 | Reduced Crypt Depth | Beneficial | Moderate |
Bacillus subtilis SNZ-1972 | Reduced Enteritis Index | Beneficial | Large |
Bacillus subtilis SNZ-1972 | Reduced Intestinal NE Lesion Score | Beneficial | Large |